M M Eyetech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.99 Cr
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.13 M
- Revenue Growth -4.96%
- Profit Growth -2.92%
- Ebitda -2.14%
- Net Worth 21.13%
- Total Assets -3.35%
About M M Eyetech
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74899DL1988PTC031827
-
Company No.
031827
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 May 1988
-
Date of AGM
26 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does M M Eyetech Private Limited offer?
M M Eyetech Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Eye Treatment, Medical Treatment Services.
Who are the key members and board of directors at M M Eyetech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritika Gupta
|
Director | 01-Oct-2022 | Current |
|
Alka Sachdev
|
Director | 01-Oct-2022 | Current |
|
Sameer Chhibber
|
Director | 01-Oct-2022 | Current |
|
Ajay Jassal
|
Director | 01-Oct-2022 | Current |
|
Mandeep Singh
|
Director | 01-Oct-2022 | Current |
Financial Performance of M M Eyetech.
M M Eyetech Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.96% decrease. The company also saw a slight decrease in profitability, with a 2.92% decrease in profit. The company's net worth Soared by an impressive increase of 21.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M M Eyetech?
In 2020, M M Eyetech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Irx Pharmaceuticals Private LimitedRitika Gupta is a mutual person
-
Ndcfs FoundationRitika Gupta and Alka Sachdev are mutual person
-
Vishwanethra Health Services Private LimitedRitika Gupta and Alka Sachdev are mutual person
-
Challa Eye Care Private LimitedRitika Gupta and Alka Sachdev are mutual person
-
Dr. Khunger Eye Care And Research Centre Private LimitedRitika Gupta and Alka Sachdev are mutual person
-
New Delhi Centre For Sight Limited
Ritika Gupta and Alka Sachdev are mutual person
Charges (Loans)
₹0
₹0.41 Cr
Charges Breakdown by Lending Institutions
- Icici Bank Ltd. : 0.28 Cr
- Uco Bank : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2005 | Icici Bank Ltd. | ₹2.83 M | Satisfied |
| 22 Aug 1991 | Uco Bank | ₹1.30 M | Satisfied |
How Many Employees Work at M M Eyetech?
M M Eyetech has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M M Eyetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M M Eyetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
